Sugammadex and Decreased Time to Extubation
Diseases of the Cardiovascular System
What is the purpose of this trial?
The purpose of this study is to demonstrate faster time to extubation after arrival in the cardiothoracic intensive care unit (ICU) in patients undergoing isolated coronary artery bypass grafting (CABG) who receive Sugammadex as compared to placebo.
- Ages21 years and older
- Trial withMerck Sharp & Dohme
- Start Date09/18/2017
- End Date06/30/2020
- Last Updated07/15/2021
- Study HIC#2000021124